Hydroxyurea-induced dermatomyositis-like eruption - 29/08/11
Doi : 10.1067/mjd.2003.74
Abstract |
Hydroxyurea is a cytotoxic chemotherapeutic agent used for myelodysplasia. The adverse cutaneous effects due to hydroxyurea include leg ulcers, hyperpigmentation of the skin and nails, a lichen planus-like eruption, lupus erythematosus, and a dermatomyositis-like eruption. We present a case of hydroxyurea-induced dermatomyositis-like eruption and review the features of this entity as previously reported. (J Am Acad Dermatol 2003;48:439-41.)
Il testo completo di questo articolo è disponibile in PDF.Mappa
 | Funding sources: None. |
| Conflict of interest: None. |
 | Reprint requests: Jeffrey P. Callen, MD, 310 E Broadway, Suite 200, Louisville, KY 40202. E-mail: jefca@aol.com. |
| 0190-9622/2003/$30.00 + 0 |
© 2003
American Academy of Dermatology, Inc. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 48 - N° 3
P. 439-441 - marzo 2003 Ritorno al numero
Articolo precedente
- Oral and genital lichenoid reactions associated with circulating autoantibodies to desmoplakins I and II: A novel target antigen or example of epitope spreading?
- Noritaka Oyama, Jane F. Setterfield, Matthew J. Gratian, Balbir S. Bhogal, Pepe Shirlaw, Stephen J. Challacombe, Martin M. Black
- Atypical recurrent varicella in 4 patients with hemopathies
- Arjen F. Nikkels, Thierry Simonart, Alain Kentos, Corinne Liesnard, Catherine Sadzot-Delvaux, Walter Feremans, Gérald E. Piérard
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?